Potential selection of LMP1 variants in nasopharyngeal carcinoma.
about
Epstein-barr virus sequence variation-biology and diseaseNovel mechanisms of EBV-induced oncogenesisGenetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activationGenetic polymorphisms of TLR3 are associated with Nasopharyngeal carcinoma risk in Cantonese population.Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project.In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinomaGenomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples.Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy.LMP1 strain variants: biological and molecular properties.Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation.A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer.The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A.Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technologyCharacteristics of epstein barr virus variants associated with gastric carcinoma in Southern Tunisia.Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphismsValidation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting.Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma ProgressionModulation of LMP1 protein expression by EBV-encoded microRNAs.A novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association.The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphomaComparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytesImmunohistochemical expression of latent membrane protein 1 (LMP1) and p53 in nasopharyngeal carcinoma: Moroccan experience.Identification of a novel variant of LMP-1 of EBV in patients with endemic Burkitt lymphoma in western KenyaThe extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma.Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma.Epigenetics and Genetics of Viral Latency.Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients.Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1.Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.A simplified tumour model established via Epstein-Barr virus-encoded, nasopharyngeal carcinoma-derived oncogene latent membrane protein 1 in immunocompetent mice.Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopesEpstein-barr virus latent membrane protein 1 polymorphism in nasopharyngeal carcinoma and other oral cavity tumors in Russia.Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patient.
P2860
Q27003183-0DFE3773-9A76-4F26-B0DB-844F971CF1CAQ27006524-EAEA07E3-3BC4-4B08-9B98-C59568C32F4EQ28731826-FB854B6B-8D05-476D-B72D-696A119406E2Q33302872-65B71AC2-BEA7-453B-9F18-DFFC41728011Q33911843-1CA05A08-72A2-4CA8-A4A6-DBF1EBDF1712Q33925373-4EBCEC58-FEEF-4AC9-B443-B71263708FEEQ34092709-0133A980-1642-425E-A157-35FC9F472C42Q34173615-95FE7300-DF63-4A3B-B66F-FCB490BF0A9FQ34228526-5F61CE3E-79CB-4AF9-A28D-E3552B395938Q34262322-7C22E123-8E67-478F-BBBF-9BBB2968DF6BQ34271121-BC69E611-48ED-40E4-9616-C75223AB612BQ34717145-F3B6670F-92D2-49CC-A1B5-2C30A59EF958Q34770812-9D12F178-BEDB-421B-9DD2-FAE4EC354ACDQ35121627-1BD50083-3646-4B56-A4BF-FA833F3742B0Q35236817-F4DF6A62-83A4-4440-A6DA-8FD2B1E29371Q35363383-4411FEAA-965A-45D9-BB26-7058A090CBAEQ35550673-C75D8B5A-CD44-4038-AA07-E02C4293BA9DQ35620244-F54AC88C-0B4F-463E-86F1-68843111FF2FQ35807158-C95D4D0E-DB5F-4E10-B3A5-D326E5E3867CQ35807886-2DD01C03-8C43-4908-BBD8-E11388746C80Q35987387-5227E796-FCFD-4093-BD75-DE35630676CEQ36092565-10F58C31-15E2-4ECC-A924-35A2E7D5CD3DQ36318425-87361431-E89A-497C-B827-30BD80DE1BCAQ36457849-EF26EBFD-943A-4E26-A002-93C5F2BF8C1FQ37112849-5564221B-D9DA-416D-B24F-86DC86EA954DQ37299057-EE9E86F8-7C33-4187-BC8C-32A9A2860BB9Q37356629-17DA9F00-CF15-40F5-B126-3404AC8C49D0Q37549340-1E354FFB-FA34-41E6-9D70-5B8FB6E7C5A2Q37575613-27F37005-B344-4DE8-929C-6D7ECBDBCF77Q38779524-0388E86A-8D85-4AFB-9345-70638D5B88DEQ38803361-DF6372EC-D7D9-4FFA-9BE7-276558786644Q38833222-74010611-5B1B-4FC0-9E83-3A52DA17411BQ38855080-279F29F3-8B54-493D-8CFD-B1475088226CQ38961888-55AE300D-983B-4BC7-9AF9-0C68170F2109Q39115333-880A7BCA-ECB7-46F9-9637-ED73A14EFD29Q39537817-D8BF4933-77A2-4E57-8A1F-A6D9248E8EFFQ39988522-7CCDBCB0-9648-4E7E-AAC0-4E7980153C16Q42027228-DA2889C3-7500-4AA8-B16D-AE4874E1BA87Q42271849-D1CAF912-B26B-47B0-8EAC-037D09B00CA5Q43410058-71D4FDE4-1A60-4263-97D9-852A34421EB6
P2860
Potential selection of LMP1 variants in nasopharyngeal carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Potential selection of LMP1 variants in nasopharyngeal carcinoma.
@en
type
label
Potential selection of LMP1 variants in nasopharyngeal carcinoma.
@en
prefLabel
Potential selection of LMP1 variants in nasopharyngeal carcinoma.
@en
P2093
P2860
P1433
P1476
Potential selection of LMP1 variants in nasopharyngeal carcinoma.
@en
P2093
Diane Sitki-Green
Dominic T Moore
Nancy Raab-Traub
Rachel H Edwards
P2860
P304
P356
10.1128/JVI.78.2.868-881.2004
P407
P577
2004-01-01T00:00:00Z